시장보고서

상품코드

1927672

감염증용 진단 시약 시장 : 제품 유형별, 기술별, 질환 유형별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 점유율, 예측(2025-2032년)

Diagnostic Reagents for Infectious Diseases Market, By Product Type, By Technology, By Disease Type, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: 2026년 01월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 356 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

감염증용 진단 시약 시장 규모는 2024년에 33억 1,531만 달러로 평가되며, 2025-2032년에 CAGR 9.23%로 확대하고 있습니다.

감염성 질환 진단 시약은 세균, 바이러스, 진균, 곰팡이, 기생충을 정확하게 식별하여 병원체를 검출하는 데 사용되는 필수 생화학 물질입니다. 감염성 질환의 확산과 병원 및 검사실의 조기 및 정밀진단에 대한 수요 증가가 시장 성장을 촉진하고 있습니다. 고감도 시약의 개발 기회가 존재하며, 신속, 자동화, 현장 진단 플랫폼과 호환이 가능하며, 발병 관리 및 분산형 검사에 있으며, 매우 중요합니다. 눈에 띄는 동향으로는 보다 빠른 결과 제공과 특이성 향상을 실현하는 분자진단 및 면역측정 기반 시약의 발전을 들 수 있습니다. 그러나 시약의 안정성 한계, 콜드체인 의존성, 병원체별 성능 변동 등의 문제로 인해 자원이 한정된 환경에서의 도입과 비상상황에 대비한 장기 비축에 제약이 있습니다.

감염성 질환 진단 시약 시장 역학

감염병 확산과 진단검사 수요 증가로 진단검사 수요 증가

호흡기 감염, 결핵, HIV, 신종 바이러스 감염 등 감염성 질환의 확산은 정확하고 신속한 질병 검출에 필수적인 감염성 질환 진단 시약에 대한 수요를 크게 견인하고 있습니다. 헬스케어 시스템이 조기 진단과 효과적인 질병 관리를 점점 더 중요시하는 가운데, 검사 기관과 병원에서는 진단 플랫폼 전반에 걸쳐 민감도, 특이성, 재현성을 보장하는 고품질 시약이 요구되고 있습니다. 진단 시약은 병원체 동정, 항원 항체 반응, 핵산 증폭을 가능하게 하여 분자진단, 면역측정, 신속 진단 검사에서 매우 중요한 역할을 합니다. 신속하고 신속한 현장 진단으로의 전환이 진행됨에 따라 컴팩트하고 자동화된 시스템에서 일관된 성능을 제공하는 시약에 대한 수요는 더욱 증가하고 있습니다. 또한 질병 감시 프로그램의 확대와 정기적인 검진 정책으로 인해 시약의 소비가 가속화되고 있습니다. 예를 들어 최근 국가적 공중보건 정책으로 인해 감염병 진단 검사량이 크게 증가하고 있습니다. 또한 예방 의료, 병원 감염 관리, 감염병 발생 대비를 위한 진단 검사의 사용 확대는 의료 현장 전반에서 신뢰할 수 있는 고성능 진단 시약의 필요성을 지속적으로 견인하고 있습니다.

감염성 질환 진단 시약 시장 : 세분화 분석

감염성 질환 진단 시약 세계 시장은 제품 유형, 기술, 질병 유형, 응용 분야, 최종사용자, 지역별로 세분화되어 있습니다.

제품 유형에 따른 시장 세분화는 분자진단 시약, 면역측정 시약, 임상화학 시약, 혈액학 시약의 4 가지 유형으로 분류됩니다. 제품 유형 중 분자진단 시약은 감염성 질환 진단 시약 시장에서 가장 우선적인 위치를 차지하고 있습니다. 이는 병원체의 DNA 또는 RNA를 검출하는 높은 민감도와 특이성을 바탕으로 바이러스 및 세균 감염의 신속하고 정확한 진단에 필수적이기 때문입니다. 면역측정 시약은 2위를 차지하고 있으며, 신뢰성과 확장성, 그리고 진료 현장(Point of Care)에서 검사실 환경까지 폭넓은 적용성으로 인해 항원 항체 기반 검사에 널리 사용되고 있습니다. 임상화학 시약은 바이오마커 모니터링 및 질병 진행 추적과 같은 보조 검사를 지원하여 주요 감염성 질환 진단을 보완할 수 있습니다. 혈액학 시약은 규모는 작지만 중요한 비중을 차지하고 있으며, 특히 병원 검사실에서 감염관리의 혈구 분석 및 면역반응 모니터링에 사용됩니다. 전반적으로 시장의 우선순위는 임상적 유용성, 기술적 복잡성, 그리고 신속하고 고성능의 진단 솔루션에 대한 수요를 반영하고 있습니다.

시장은 기술에 따라 PCR/RT-PCR, ELISA, 면역형광법, 차세대 시퀀싱(NGS)의 4가지 부문으로 분류됩니다. 기술 유형 중에서는 PCR, RT-PCR이 감염성 질환 진단 시약 시장에서 가장 우선순위를 차지하고 있습니다. 그 이유는 광범위한 채택 실적, 높은 민감도, 병원균의 신속한 핵산 기반 검출 능력으로 분자진단의 표준으로 자리 잡았기 때문입니다. ELISA는 견고성, 조작의 용이성, 광범위한 감염성 질환의 항원 및 항체 검출에 대한 적용성을 높이 평가받아 2위를 차지했습니다. 면역 형광법은 특히 전문 실험실 응용 분야에서 병원균의 정밀한 시각화 및 검출을 제공하지만, 첨단 기술적 전문 지식이 필요합니다. 차세대 염기서열 분석(NGS)은 종합적인 병원체 프로파일링 및 발병 추적에 있으며, 잠재력이 높은 기술로 부상하고 있지만, 높은 비용과 인프라 요구 사항으로 인해 도입이 제한되고 있습니다. 전반적으로 우선순위는 임상 진단의 민감도, 사용 용이성, 확장성을 반영하고 있습니다.

감염성 질환 진단 시약 시장 - 지역별 분석

북미는 감염성 질환 진단 시약 시장을 주도하며 가장 큰 매출 점유율을 차지하고 있습니다. 이는 탄탄한 헬스케어 인프라, 막대한 R&D 투자, 첨단 분자진단 및 면역측정 시약의 보급이 임상 현장과 실험실 환경 수요를 견인하고 있기 때문입니다. 미국은 정부의 스크리닝 프로그램과 민간 부문의 적극적인 참여에 힘입어 지역 성장을 주도하고 있습니다. 유럽은 두 번째 점유율을 차지하고 있으며, 독일, 프랑스, 영국 등의 국가에서는 공공-민간 파트너십을 통한 검사 역량 확대를 배경으로 질병의 조기 발견과 고품질 시약의 도입이 강조되고 있습니다. 아시아태평양은 의료비 지출 증가, 검사 시설 인프라 확충, 특히 중국, 인도, 일본의 감염성 질환 유병률 증가로 인해 가장 빠르게 성장하는 시장으로 부상하고 있습니다. 이를 통해 현지 시약 사용과 생산을 촉진하고 있습니다. 전략적 동향으로는 2025년 6월 바이오메뤼가 시약 포트폴리오 확장을 위해 데이제로다이애그노스틱스를 인수한 점, 2025년 10월 시스멕스와 QIAGEN이 일본내 시약 공급 및 유통을 위해 제휴한 점 등을 들 수 있습니다.

감염성 질환 진단 시약 시장 - 국가별 분석

국가별로는 미국이 감염성 질환 진단 시약 시장에서 선도적인 위치를 차지하고 있습니다. 이는 첨단 의료 인프라, 분자 검사의 꾸준한 보급, 그리고 질병 조기 발견을 위한 공공 및 민간 부문의 막대한 투자에 힘입은 바 큽니다. 독일, 영국, 프랑스 등 서유럽 국가들은 확장된 검사 네트워크와 임상 진단 및 공중보건 검진 프로그램에서의 강력한 시약 활용에 힘입어 그 뒤를 잇고 있습니다. 아시아태평양에서는 의료비 지출 증가, 감염성 질환 유병률 증가, 수입 의존도를 줄이기 위한 시약 공급망 현지화 구상로 인해 중국과 인도가 시약 시장을 빠르게 확장하고 있으며, 지역내 접근성 향상과 비용 절감을 위해 시약 시장을 빠르게 확대하고 있습니다.

전략적인 동향으로는 바이오메트류가 2025년 6월 데이제로다이애그노스틱스를 인수하여 감염병 시약 포트폴리오와 차세대염기서열분석(NGS) 역량을 확대한 점, 시스멕스가 2025년 10월 QIAGEN과 제휴하여 일본내 감염병 시약 판매를 개시한 점 등이 있습니다. 시약 및 진단 제품 판매를 개시한 것을 들 수 있습니다.

서론
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 네덜란드
- 스웨덴
- 러시아
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 중국
- 인도
- 일본
- 한국
- 호주
- 인도네시아
- 태국
- 필리핀
- 기타
라틴아메리카(LATAM)
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 튀르키예
- 알제리
- 이집트
- 기타

제13장 주요 벤더 분석 : 감염증용 진단 시약 업계

경쟁 대시보드
- 경쟁 벤치마킹
- 경쟁 포지셔닝
기업 개요
- Abbott Laboratories
- Agilent Technologies
- Beckman Coulter
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Danaher Corporation
- DiaSorin
- Fujirebio
- Grifols
- Hologic
- Merck KGaA
- Ortho Clinical Diagnostics
- QIAGEN
- QuidelOrtho
- Randox Laboratories
- Roche Diagnostics
- Sekisui Diagnostics
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific
- Others

제14장 AnalystView의 전방위적 분석

KSA 26.02.25

The Diagnostic Reagents for Infectious Diseases Market size was valued at US$ 3,315.31 Million in 2024, expanding at a CAGR of 9.23% from 2025 to 2032.

Diagnostic reagents for infectious diseases are essential biochemical substances used to detect pathogens by enabling accurate identification of bacteria, viruses, fungi, and parasites. The growing prevalence of infectious diseases and rising demand for early and precise diagnosis across hospitals and laboratories are driving market growth. Opportunities exist in developing high-sensitivity reagents compatible with rapid, automated, and point-of-care diagnostic platforms, which are critical for outbreak management and decentralized testing. A prominent trend is the advancement of molecular and immunoassay-based reagents that offer faster turnaround times and improved specificity. However, challenges such as limited reagent stability, cold-chain dependency, and variability in performance across different pathogens restrict adoption in resource-limited settings and long-term stockpiling for emergency preparedness.

Diagnostic Reagents for Infectious Diseases Market- Market Dynamics

Increasing prevalence of infectious diseases and expanding diagnostic testing

The rising prevalence of infectious diseases such as respiratory infections, tuberculosis, HIV, and emerging viral outbreaks is significantly driving demand for diagnostic reagents for infectious diseases, which are critical for accurate and timely disease detection. As healthcare systems increasingly prioritize early diagnosis and effective disease management, laboratories and hospitals require high-quality reagents that ensure sensitivity, specificity, and reproducibility across diagnostic platforms. Diagnostic reagents play a vital role in molecular, immunoassay, and rapid diagnostic tests by enabling pathogen identification, antigen-antibody reactions, and nucleic acid amplification. The growing shift toward rapid and point-of-care diagnostics further increases demand for reagents that deliver consistent performance in compact and automated systems. Moreover, expanding disease surveillance programs and routine screening initiatives are accelerating reagent consumption. For instance, national public health initiatives have significantly increased diagnostic testing volumes for infectious diseases in recent years. Additionally, the growing use of diagnostic testing in preventive healthcare, hospital infection control, and outbreak preparedness continues to drive the need for reliable, high-performance diagnostic reagents across healthcare settings.

Diagnostic Reagents for Infectious Diseases Market- Segmentation Analysis:

The Global Diagnostic Reagents for Infectious Diseases Market is segmented on the basis of Product Type, Technology, Disease Type, Application, End-User, and Region.

The market is segmented into four categories based on product type: molecular diagnostic reagents, immunoassay reagents, clinical chemistry reagents, and hematology reagents. Among product types, Molecular Diagnostic Reagents hold the highest priority in the diagnostic reagents for infectious diseases market, driven by their high sensitivity and specificity for detecting pathogen DNA or RNA, making them essential for rapid and accurate diagnosis of viral and bacterial infections. Immunoassay Reagents rank second, widely used in antigen-antibody-based testing due to their reliability, scalability, and applicability across point-of-care and laboratory settings. Clinical Chemistry Reagents follow, supporting supportive testing such as monitoring biomarkers and disease progression, which complements primary infectious disease diagnostics. Hematology Reagents hold a smaller yet significant share, as they are used for blood cell analysis and immune response monitoring in infection management, particularly in hospital laboratories. Overall, market prioritization reflects clinical utility, technological complexity, and demand for rapid, high-performance diagnostic solutions.

The market is categorized into four segments based on technology: PCR & RT-PCR, ELISA, immunofluorescence, and next-generation sequencing (NGS). Among technology types, PCR & RT-PCR hold the highest priority in the diagnostic reagents for infectious diseases market due to their widespread adoption, high sensitivity, and ability to provide rapid nucleic acid-based detection of pathogens, making them the gold standard for molecular diagnostics. ELISA ranks second, valued for its robustness, ease of use, and applicability in detecting antigens and antibodies across a wide range of infectious diseases in both laboratory and point-of-care settings. Immunofluorescence follows, offering precise visualization and detection of pathogens, particularly in specialized laboratory applications, though it requires more technical expertise. Next-Generation Sequencing (NGS) ranks next, emerging as a high-potential technology for comprehensive pathogen profiling and outbreak tracking, yet its adoption is limited by higher costs and infrastructure requirements. Overall, prioritization reflects sensitivity, usability, and scalability in clinical diagnostics.

Diagnostic Reagents for Infectious Diseases Market- Geographical Insights

North America dominates the diagnostic reagents for infectious diseases market, accounting for the largest revenue share, as robust healthcare infrastructure, significant R&D investment, and high adoption of advanced molecular and immunoassay reagents drive demand across clinical and laboratory settings. The United States leads regional growth, supported by government screening programs and strong private sector participation. Europe holds the second-largest share, with countries such as Germany, France, and the UK emphasizing early disease detection and high-quality reagent adoption, bolstered by public-private partnerships that expand testing capacity. The Asia-Pacific region is emerging as the fastest-growing market due to increased healthcare spending, expanded lab infrastructure, and rising infectious disease prevalence, particularly in China, India, and Japan, encouraging local reagent use and production. Strategic developments include bioMerieux's acquisition of Day Zero Diagnostics in June 2025 to expand reagent portfolios and an October 2025 partnership between Sysmex and QIAGEN for reagent supply and distribution in Japan.

Diagnostic Reagents for Infectious Diseases Market- Country Insights

At the country level, the United States commands a leading position in the diagnostic reagents for infectious diseases market, propelled by advanced healthcare infrastructure, robust molecular testing adoption, and significant public and private investment in early disease detection. Western European countries such as Germany, the United Kingdom, and France follow closely, supported by expanding laboratory networks and strong reagent utilization in both clinical diagnostics and public health screening programs. In the Asia-Pacific region, China and India are rapidly expanding reagent markets due to increased healthcare spending, rising infectious disease prevalence, and initiatives to localize reagent supply chains to reduce dependence on imports, enhancing regional accessibility and reducing costs.

Strategic developments include bioMerieux's acquisition of Day Zero Diagnostics in June 2025 to broaden its infectious disease reagent portfolio and NGS capabilities, and Sysmex's collaboration with QIAGEN in October 2025 to distribute infectious disease reagents and diagnostic products in Japan.

Diagnostic Reagents for Infectious Diseases Market- Competitive Landscape:

The competitive landscape of the diagnostic reagents for infectious diseases market is moderately consolidated, with established players such as bioMerieux SA, QIAGEN, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Danaher Corporation, and Sysmex Corporation leading through extensive reagent portfolios, global distribution networks, and ongoing innovation in molecular and immunoassay technologies. Continuous investment in R&D, reagent sensitivity, and automation capabilities differentiates market leaders while fostering competition. Mergers and acquisitions are shaping market dynamics; for example, bioMerieux's acquisition of Day Zero Diagnostics in June 2025 expanded its infectious disease reagent offerings and next-generation sequencing workflows. Strategic collaborations also strengthen competitive positioning, such as the Sysmex partnership with QIAGEN in October 2025 for exclusive distribution of infectious disease reagents and diagnostic products in Japan. Smaller firms focus on niche reagent solutions to capture specialized segments, balancing the innovation ecosystem.

Recent Developments:

In January 2024, QIAGEN launched two new QIAstat-Dx syndromic test panels in India-the Gastrointestinal Panel 2 and the Meningitis/Encephalitis Panel-joining the existing Respiratory SARS-CoV-2 Panel to enable rapid, accurate, multiplex infectious disease diagnosis using real-time PCR and single-use cartridges.

In July 2025, Microbix Biosystems launched its QUANTDx(TM) characterized reference materials, a new product line of accurately quantified and fully traceable reference materials covering more than 80 panels for infectious disease assay development and validation, aimed at improving diagnostic assay performance and regulatory readiness.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott Laboratories
Agilent Technologies
Beckman Coulter
Becton, Dickinson and Company
Bio-Rad Laboratories
Danaher Corporation
DiaSorin
Fujirebio
Grifols
Hologic
Merck KGaA
Ortho Clinical Diagnostics
QIAGEN
QuidelOrtho
Randox Laboratories
Roche Diagnostics
Sekisui Diagnostics
Siemens Healthineers
Sysmex Corporation
Thermo Fisher Scientific
Others

GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Molecular Diagnostic Reagents
Immunoassay Reagents
Clinical Chemistry Reagents
Hematology Reagents

GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

PCR & RT-PCR
ELISA
Immunofluorescence
Next-Generation Sequencing

GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032

Viral Infections
Bacterial Infections
Fungal Infections
Parasitic Infections

GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Disease Diagnosis
Blood Screening
Epidemiological Surveillance

GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Diagnostic Laboratories
Blood Banks
Research Institutes

GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Diagnostic Reagents for Infectious Diseases Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Diagnostic Reagents for Infectious Diseases Market Snippet by Product Type
- 2.1.2. Diagnostic Reagents for Infectious Diseases Market Snippet by Technology
- 2.1.3. Diagnostic Reagents for Infectious Diseases Market Snippet by Disease Type
- 2.1.4. Diagnostic Reagents for Infectious Diseases Market Snippet by Application
- 2.1.5. Diagnostic Reagents for Infectious Diseases Market Snippet by End-User
- 2.1.6. Diagnostic Reagents for Infectious Diseases Market Snippet by Country
- 2.1.7. Diagnostic Reagents for Infectious Diseases Market Snippet by Region
2.2. Competitive Insights

3. Diagnostic Reagents for Infectious Diseases Key Market Trends

3.1. Diagnostic Reagents for Infectious Diseases Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Diagnostic Reagents for Infectious Diseases Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Diagnostic Reagents for Infectious Diseases Market Opportunities
3.4. Diagnostic Reagents for Infectious Diseases Market Future Trends

4. Diagnostic Reagents for Infectious Diseases Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Diagnostic Reagents for Infectious Diseases Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Diagnostic Reagents for Infectious Diseases Market Landscape

6.1. Diagnostic Reagents for Infectious Diseases Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Diagnostic Reagents for Infectious Diseases Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 7.1.2. Molecular Diagnostic Reagents
- 7.1.3. Immunoassay Reagents
- 7.1.4. Clinical Chemistry Reagents
- 7.1.5. Hematology Reagents

8. Diagnostic Reagents for Infectious Diseases Market - By Technology

8.1. Overview
- 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
- 8.1.2. PCR & RT-PCR
- 8.1.3. ELISA
- 8.1.4. Immunofluorescence
- 8.1.5. Next-Generation Sequencing

9. Diagnostic Reagents for Infectious Diseases Market - By Disease Type

9.1. Overview
- 9.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
- 9.1.2. Viral Infections
- 9.1.3. Bacterial Infections
- 9.1.4. Fungal Infections
- 9.1.5. Parasitic Infections

10. Diagnostic Reagents for Infectious Diseases Market - By Application

10.1. Overview
- 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 10.1.2. Disease Diagnosis
- 10.1.3. Blood Screening
- 10.1.4. Epidemiological Surveillance

11. Diagnostic Reagents for Infectious Diseases Market - By End-User

11.1. Overview
- 11.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
- 11.1.2. Hospitals
- 11.1.3. Diagnostic Laboratories
- 11.1.4. Blood Banks
- 11.1.5. Research Institutes

12. Diagnostic Reagents for Infectious Diseases Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Diagnostic Reagents for Infectious Diseases Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Diagnostic Reagents for Infectious Diseases Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.3.10. UK
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.10.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.3.10.5. UK Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.3.10.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.10.7. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.3.11. France
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.3.11.5. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.11.7. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.3.12. Italy
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.12.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.3.12.5. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.3.12.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.12.7. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.3.13. Spain
  - 12.3.13.1. Overview
  - 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.13.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.3.13.5. Spain Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.3.13.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.13.7. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.3.14. The Netherlands
  - 12.3.14.1. Overview
  - 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.3.14.5. The Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.14.7. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Overview
  - 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.15.7. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.3.16. Russia
  - 12.3.16.1. Overview
  - 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.16.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.3.16.5. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.3.16.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.16.7. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.3.17. Poland
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.17.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.3.17.5. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.17.7. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.3.18. Rest of Europe
  - 12.3.18.1. Overview
  - 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.3.18.5. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.18.7. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Diagnostic Reagents for Infectious Diseases Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.4.9. China
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.4.9.5. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.9.7. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.4.10. India
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.10.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.4.10.5. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.4.10.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.10.7. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.4.14. Indonesia
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.4.14.5. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.14.7. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.4.15. Thailand
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.15.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.4.15.5. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.4.15.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.15.7. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. Diagnostic Reagents for Infectious Diseases Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Diagnostic Reagents for Infectious Diseases Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Diagnostic Reagents for Infectious Diseases Industry

13.1. Competitive Dashboard
- 13.1.1. Competitive Benchmarking
- 13.1.2. Competitive Positioning
13.2. Company Profiles
- 13.2.1. Abbott Laboratories
- 13.2.2. Agilent Technologies
- 13.2.3. Beckman Coulter
- 13.2.4. Becton, Dickinson and Company
- 13.2.5. Bio-Rad Laboratories
- 13.2.6. Danaher Corporation
- 13.2.7. DiaSorin
- 13.2.8. Fujirebio
- 13.2.9. Grifols
- 13.2.10. Hologic
- 13.2.11. Merck KGaA
- 13.2.12. Ortho Clinical Diagnostics
- 13.2.13. QIAGEN
- 13.2.14. QuidelOrtho
- 13.2.15. Randox Laboratories
- 13.2.16. Roche Diagnostics
- 13.2.17. Sekisui Diagnostics
- 13.2.18. Siemens Healthineers
- 13.2.19. Sysmex Corporation
- 13.2.20. Thermo Fisher Scientific
- 13.2.21. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us